Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice.

CONCLUSIONS: In DOAC therapy for cancer-associated VTE, major bleeding prevention is important because it is an independent risk factor of death.
PMID: 32624519 [PubMed - as supplied by publisher]

Source: Circulation Journal - July 3, 2020 Category: Cardiology Authors: Ogino Y, Ishigami T, Minamimoto Y, Kimura Y, Akiyama E, Okada K, Matsuzawa Y, Maejima N, Iwahashi N, Hibi K, Kosuge M, Ebina T, Ishikawa T, Tamura K, Kimura K Tags: Circ J Source Type: research